Tag: Biopharmaceutical company
Press release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA have expanded their strategic alliance by partnering on AVT03, a biosimilar to Prolia® and Xgeva® (denosumab) for the treatment of osteoporosis...
Newron Pharmaceuticals Will Host Its 2024 Investor Day on June 25 in New York...
New Hope for Treatment-Resistant Schizophrenia Revealed at Newron Pharmaceuticals 2024 Investor DayNewron Pharmaceuticals S.p.A. announced its upcoming 2024 Investor Day on June 25, 2024,...
BREAKING NEWS
French Elections Round Two, Powell Testimony, and US CPI Preview –...
Traders are eagerly watching the outcome of the French election, with the far-right National Rally (RN) leading the first round but facing opposition from...
